QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026)

QuidelOrtho (QDEL) reported Liabilities and Shareholders Equity of $5.6 billion for Q1 2026, down 12.89% on a YoY basis from $6.5 billion in Q1 2025, and down 2.44% sequentially from $5.8 billion in Q4 2025.

QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

QuidelOrtho (QDEL) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $5.6 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 12.89% year-over-year to $5.6 billion; the trailing twelve-month figure through Mar 2026 stood at $23.5 billion (down 11.08% YoY), and the FY2025 full-year result was $5.8 billion, down 10.19% from the prior year.
  • Liabilities and Shareholders Equity retreated to $5.6 billion in Q1 2026, from $5.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.9 billion in Q1 2023 to a low of $2.4 billion in Q1 2022.
  • A 5-year average of $7.0 billion and a median of $6.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity surged 264.38% in 2023 and dropped 24.99% in 2024, its largest moves.
  • Tracing QDEL's Liabilities and Shareholders Equity over 5 years: stood at $8.7 billion in 2022, then declined by 1.07% to $8.6 billion in 2023, then slipped by 24.99% to $6.4 billion in 2024, then retreated by 10.19% to $5.8 billion in 2025, then dropped by 2.44% to $5.6 billion in 2026.
  • Business Quant data shows QDEL's Liabilities and Shareholders Equity at $5.6 billion in Q1 2026, $5.8 billion in Q4 2025, and $5.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 QuidelOrtho 1.13 Bn 990.36 Mn - 5.63 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 5.63 Bn
Dec 28, 2025 5.77 Bn
Sep 28, 2025 5.68 Bn
Jun 29, 2025 6.38 Bn
Mar 30, 2025 6.46 Bn
Dec 29, 2024 6.42 Bn
Sep 29, 2024 6.80 Bn
Jun 30, 2024 6.69 Bn
Mar 31, 2024 6.70 Bn
Dec 31, 2023 8.56 Bn
Oct 1, 2023 8.54 Bn
Jul 2, 2023 8.55 Bn
Apr 2, 2023 8.79 Bn
Jan 1, 2023 8.86 Bn
Oct 2, 2022 8.66 Bn
Jul 3, 2022 8.82 Bn
Jan 2, 2022 2.43 Bn